SILVERMAN, G. J., & PELZEK, A. (2014). Rheumatoid Arthritis Clinical Benefits from Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses. J Rheumatol.
シカゴスタイル引用形SILVERMAN, GREGG J., , ADAM PELZEK. "Rheumatoid Arthritis Clinical Benefits From Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses." J Rheumatol 2014.
MLA引用形式SILVERMAN, GREGG J., , ADAM PELZEK. "Rheumatoid Arthritis Clinical Benefits From Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses." J Rheumatol 2014.
警告: この引用は必ずしも正確ではありません.